Figure 1. ML and CL patients produce IgG antibodies against Leishmania braziliensisantigens. Anti-SLA total IgG (A), IgG1 (B) and IgG2 (C) titers from ML and CL patients, performed by ELISA technique.
Supplemental data for "Comprehensive plasma cytokine profiling reveals a distinct endotype of Type 2 Inflammation in Chronic Pruritus of Unknown Origin"
Median and IQR are shown for the subjects without history of leishmaniasis (NH), asymptomatic immune responders to Leishmania (NH-AIRL), patients cured of VL (CVL) and patients with active VL (VL). (
